| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Commentary on “Primary Systemic Anaplastic Large-Cell Lymphoma (CD30+): Advances in Biology and Current Therapeutic Approaches”
|
Lynch Jr., James W.
|
|
2001
|
2 |
1 |
p. 38-39
2 p.
|
artikel
|
| 2 |
Editorial
|
Armitage, James O.
|
|
2001
|
2 |
1 |
p. 10-
1 p.
|
artikel
|
| 3 |
Highlights From: 37th Annual American Society of Clinical Oncology Meeting, San Francisco, CA May 12–15, 2001
|
D'Orazio, Amy I.
|
|
2001
|
2 |
1 |
p. 11-17
7 p.
|
artikel
|
| 4 |
Management of Patients with Multiple Myeloma: Emphasizing the Role of High-Dose Therapy
|
Kyle, Robert A.
|
|
2001
|
2 |
1 |
p. 21-28
8 p.
|
artikel
|
| 5 |
Molecular Aspects of B-Cell Lymphomas of the Gastrointestinal Tract
|
Barth, Thomas F.E
|
|
2001
|
2 |
1 |
p. 57-64
8 p.
|
artikel
|
| 6 |
Non-Hodgkin's Lymphoma Affecting the Testis: Is It Curable with Doxorubicin-Based Therapy?
|
Visco, Carlo
|
|
2001
|
2 |
1 |
p. 40-46
7 p.
|
artikel
|
| 7 |
Phase II Trials of EPOCH/Rituximab in Patients with Aggressive Lymphomas
|
D'Orazio, Amy I.
|
|
2001
|
2 |
1 |
p. 18-20
3 p.
|
artikel
|
| 8 |
Primary Systemic Anaplastic Large-Cell Lymphoma (CD30+): Advances in Biology and Current Therapeutic Approaches
|
Fiorani, Claudia
|
|
2001
|
2 |
1 |
p. 29-37
9 p.
|
artikel
|
| 9 |
The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis
|
Morrison, Vicki A.
|
|
2001
|
2 |
1 |
p. 47-56
10 p.
|
artikel
|
Tijdschrift beschrijving